Toggle Main Menu Toggle Search

Open Access padlockePrints

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis

Lookup NU author(s): James Clark, Dr Simon CockellORCiD, Emerita Professor Ann Daly, Professor Dina Tiniakos, Professor Quentin AnsteeORCiD, Dr Lizah Van der AartORCiD, Dr Olivier Govaere

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© The Author(s) 2026. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic condition impacting over 30% population, yet the dynamic changes in macrophage composition from steatosis to steatohepatitis (metabolic dysfunction-associated steatohepatitis, MASH) remain unclear. Here, by integrating single-nucleus transcriptomics, spatial multi-omics and proteomics on human samples, we delineate the evolving landscape of hepatic macrophages across the MASLD spectrum. Our analysis reveals a progressive depletion of Kupffer cells accompanied by the emergence of diverse, phenotypically distinct macrophage subsets. Spatial multi-omics further demonstrates that disease progression toward MASH is marked by an accumulation of antigen-presenting, phagocytic GPNMB+ macrophages, supported by IL32-producing hepatocytes. These macrophages showed an adaptive metabolic and pro-inflammatory phenotype that is tightly regulated by both spatial context and disease stage. Identified macrophage markers enable patient stratification by disease activity and its stage across independent clinical cohorts. Our study sheds light on the diversity of macrophage identities and metabolic-adaptive phenotypes during the progression of MASLD.


Publication metadata

Author(s): Boesch M, Anak S, El Abyad D, Ostyn T, Antoranz A, My Van T, Newhouse D, Myers C, Van Melkebeke L, Palmer J, Saffarzadeh N, Chui JS-H, Feio-Azevedo R, Smets L, Shankar G, Dubroja Lakic N, Calvo PL, Voet T, Clark J, Cockell S, Lannoo M, Deleus E, Jaekers J, Topal H, Topal B, Schneider KM, Vacca M, Allison M, Ekstedt M, Boursier J, Bugianesi E, Ratziu V, De Smet F, Boeckx B, Daly AK, Schattenberg JM, Verbeek J, Bosisio F, Lambrechts D, Roskams T, Schneider CV, Francque S, Korf H, Hartlova A, Tiniakos D, Anstee QM, van der Merwe S, Govaere O

Publication type: Article

Publication status: Published

Journal: Nature Genetics

Year: 2026

Pages: Epub ahead of print

Online publication date: 18/05/2026

Acceptance date: 14/04/2026

ISSN (print): 1061-4036

ISSN (electronic): 1546-1718

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41588-026-02600-3

DOI: 10.1038/s41588-026-02600-3

PubMed id: 42151416


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
777377European Commission
NanoString/Bruker WTA grant UK/Ireland
Newcastle NIHR Biomedical Research Centre
Research Foundation—Flanders (FWO; project G032324N)

Share